Tissue Diagnostics (TDx) Market, By Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), By Technology (ISH, IHC, Special Staining), By Disease (Breast Cancer, NSCLC, Lymphoma), By End User (Hospitals, Research Laboratories) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Tissue Diagnostics (TDx) Market accounted for US$ 5699.59 million in 2020 and is estimated to be US$ 13814.7 million by 2030 and is anticipated to register a CAGR of 9.30%.

Tissue diagnostics is analysing and testing specific tissue samples in order to understand the biological background of diseases. They are used to detect certain medical problems including as cancer and inflammatory disorders, as well as indicate the precise type and degree of malignancy, which aids in the identification of potential causes and treatment choices. Tissue diagnostics are very accurate, low-cost, and can be done using a variety of procedures, including core and open biopsy. These diagnoses are now performed using modern technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special labelling.

The overall share of the geriatric population is currently growing steadily over the world due to decreased fertility rates and higher life expectancy. Because older persons are more susceptible to chronic diseases and hence require frequent check-ups and diagnoses, this is a critical element contributing to market growth. Aside from that, changes in eating habits, increased alcohol consumption, and decreased physical activity have all contributed to an increase in the prevalence of a variety of lifestyle diseases. Furthermore, the increased occurrence of many forms of malignancies in people of all ages has resulted in an increase in demand for these diagnostic services.  

Increased occurrence of many forms of malignancies in people boost the market growth

Tissue diagnostics is a vital tool for diagnosing cancer patients, as well as in pharmacological research. Tissue-based diagnostic tests play an important part in current medical practise, and they are used to diagnose a variety of disorders using a variety of tools and consumables. Tissue diagnostic goods, such as tools and consumables, must meet stringent quality standards in order to be used in tissue-based diagnostic procedures. Furthermore, the tissue diagnostics market is highly consolidated, with only a few significant competitors controlling the whole market. New entrants to this sector face significant entry hurdles due to stringent regulatory requirements and a high degree of consolidation. Modest and mid-sized businesses make up a small portion of the market, but their commercial interests are diverse.

Tissue Diagnostics (TDx) Market is segmented based on product, technology, disease, end-user and region.

Based on Product, the target market is segmented into Antibodies, Kits, Slide Staining System, Tissue Processing System. On the basis of Technology, the Global Tissue Diagnostics (TDx) Market is segmented into ISH, IHC, Special Staining. On the basis of Disease, the Global Tissue Diagnostics (TDx) Market is segmented into Breast Cancer, NSCLC, Lymphoma. Based on End-User, the target market is segmented into Hospitals, Research Laboratories.

Regional Insights:

On region the Tissue Diagnostics (TDx) Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The tissue diagnostic market in North America, dominates the market during the forecast year. North America had the biggest market share in 2019, followed by Europe. The growth of the tissue diagnostic market in North America is being fueled by easy access to advanced technologies, government initiatives for cancer screening, favourable reimbursement scenarios for pathology diagnostic tests, rising healthcare expenditures, and high-quality infrastructure for hospitals and clinical laboratories in this region.

Tissue Diagnostics (TDx) Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Tissue Diagnostics (TDx) Market report based on Technology, Product, Disease, End-User and region.

Tissue Diagnostics (TDx) Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The prominent players operating in the Tissue Diagnostics (TDx) Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), and Dipath S.P.A. (Italy).

• Roche
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Danaher
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Thermo Fisher Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Abbott
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Agilent Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Merck KGAA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Medite GMBH
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Jinhua Yidi Medical Appliance Co.Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies